Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026 and Jun 2026.
- Largest single sale: $877K (14,396 shares) of Tarsus Pharmaceuticals, Inc. on Jun 16, 2026. Filing
- Last sale before this period: Jun 17, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | Apr 26, 2023 | Jun 17, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 16, 2026, Tarsus Pharmaceuticals, Inc.: sold 14,396 shares for $877K, to cover taxes. 1 filing: 1
- Jun 15, 2026, Tarsus Pharmaceuticals, Inc.: 27,881 shares vested. 1 filing: 1
- Mar 19, 2026, Tarsus Pharmaceuticals, Inc.: sold 2,186 shares for $146K, to cover taxes. 1 filing: 1
- Mar 18, 2026, Tarsus Pharmaceuticals, Inc.: sold 2,133 shares for $147K, to cover taxes. 1 filing: 1
- Mar 17, 2026, Tarsus Pharmaceuticals, Inc.: sold 2,111 shares for $147K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.